Issue Code: PHA
2,172
491
295
2025--2026
LMH STRATEGIC SOLUTIONS
72 activities
MARSHALL & POPP, LLC
62 activities
MEHLMAN CONSULTING, INC.
55 activities
B HALL STRATEGIES, LLC
HOUSE OF REPRESENTATIVES
1,748 mentionsSENATE
1,729 mentionsHealth & Human Services, Dept of (HHS)
483 mentionsCenters For Medicare and Medicaid Services (CMS)
EXELA PHARMA SCIENCES, LLC
via OLD NORTH STRATEGIES, LLC
on shore medications
B. BRAUN MEDICAL
via B. BRAUN MEDICAL
drug quality security act, 503A and 503B pharmacy issues
52 activities
TODD STRATEGY GROUP
49 activities
RUBICON ADVISORS, LLC
44 activities
BALLARD PARTNERS
40 activities
DLA PIPER LLP (US)
39 activities
KOUNTOUPES DENHAM CARR & REID, LLC
36 activities
BGR GOVERNMENT AFFAIRS
35 activities
Food & Drug Administration (FDA)
234 mentionsWhite House Office
180 mentionsExecutive Office of the President (EOP)
128 mentionsHealth Resources & Services Administration (HRSA)
46 mentionsOffice of Management & Budget (OMB)
45 mentionsDrug Enforcement Administration (DEA)
33 mentionsPHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
via DAVE KOLBE CONSULTING
H.R. 9393 (Lower Costs, More Transparency Act of 2026) -In support of the Lower Cost, More Transparency Act as this bill will require hospitals, labs, and image providers to make price information publicly available and will help reign in Pharmacy Benefit Managers (PBMs).
CAPITAL RX INC.
via MASON STREET CONSULTING, LLC
PBM Reform.
AMERICAN COLLEGE OF CLINICAL PHARMACY
via AMERICAN COLLEGE OF CLINICAL PHARMACY
Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.
GS1 US
via KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain.
AMERICA'S POISON CENTERS
via AMERICA'S POISON CENTERS
Misdirected calls to national Poison Center system Establishing 3 digit number Federal appropriations
CVS HEALTH
via KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
via KOUNTOUPES DENHAM CARR & REID, LLC
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
HARMONY BIOSCIENCES
via HARMONY BIOSCIENCES
S. 3019 - No Big Blockbuster Bailouts Act (NOBBBA) Cameron's Law (HR 1414) EPIC Act (HR 1492, S 832) HR 1672 Maintaining Investments in New Innovation Act Issues related to protecting patient access to medicines Issues related to protecting orphan drug policies Issues related to most-favored-nation policies